Home NDC 51672-4001-05 NDC 51672-4001-05 - Nortriptyline Hydrochloride This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
Product NDC 51672-4001
Requested NDC 51672-4001-05
Package NDCs from labels 51672-4001-6, 51672-4001-5, 51672-4001-1, 51672-4001-2, 51672-4001-05
Manufacturer Bryant Ranch Prepack
Effective date 2026-08-18
Current FDA listing Not matched in FDA.report NDC product tables DailyMed Labels# Label, Manufacturer, Effective date table Label Manufacturer Effective date Type Nortriptyline Hydrochloride - Bryant Ranch Prepack Bryant Ranch Prepack 2026-08-18 HUMAN PRESCRIPTION DRUG LABEL Nortriptyline Hydrochloride Capsules, USP Sun Pharmaceutical Industries, Inc. | Taro Pharmaceutical Industries, Ltd. 2026-07-15 HUMAN PRESCRIPTION DRUG LABEL Nortriptyline Hydrochloride - Northwind Health Company, LLC Northwind Health Company, LLC 2025-12-26 HUMAN PRESCRIPTION DRUG LABEL Nortriptyline Hydrochloride Capsules, USP REMEDYREPACK INC. 2025-01-13 HUMAN PRESCRIPTION DRUG LABEL Nortriptyline Hydrochloride - American Health Packaging American Health Packaging 2024-08-07 HUMAN PRESCRIPTION DRUG LABEL Nortriptyline Hydrochloride - A-S Medication Solutions A-S Medication Solutions 2024-02-12 HUMAN PRESCRIPTION DRUG LABEL Nortriptyline Hydrochloride - AvPAK AvPAK 2024-01-08 HUMAN PRESCRIPTION DRUG LABEL Nortriptyline Hydrochloride - Denton Pharma, Inc. DBA Northwind Pharmaceuticals Denton Pharma, Inc. DBA Northwind Pharmaceuticals 2023-01-12 HUMAN PRESCRIPTION DRUG LABEL Nortriptyline Hydrochloride - Proficient Rx LP Proficient Rx LP 2023-01-01 HUMAN PRESCRIPTION DRUG LABEL Nortriptyline HCL - Direct_Rx Direct_Rx 2022-03-30 HUMAN PRESCRIPTION DRUG LABEL Nortriptyline Hydrochloride Capsules, USP NuCare Pharmaceuticals, Inc. 2021-02-11 HUMAN PRESCRIPTION DRUG LABEL Nortriptyline Hydrochloride Capsules, USP Preferred Pharmaceuticals Inc. 2020-07-31 HUMAN PRESCRIPTION DRUG LABEL Nortriptyline Hydrochloride - Clinical Solutions Wholesale, LLC Clinical Solutions Wholesale, LLC 2020-07-26 HUMAN PRESCRIPTION DRUG LABEL Nortriptyline Hydrochloride Capsules, USP REMEDYREPACK INC. 2019-10-08 HUMAN PRESCRIPTION DRUG LABEL Nortriptyline Hydrochloride Capsules, USP REMEDYREPACK INC. 2019-09-17 HUMAN PRESCRIPTION DRUG LABEL Nortriptyline Hydrochloride Capsules, USP St. Mary's Medical Park Pharmacy | Taro Pharmaceutical Industries, Ltd. 2018-11-16 HUMAN PRESCRIPTION DRUG LABEL Nortriptyline Hydrochloride - Medsource Pharmaceuticals Medsource Pharmaceuticals 2018-07-19 HUMAN PRESCRIPTION DRUG LABEL
DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 51672-4001-1 Nortriptyline Hydrochloride 100 in 1 BOTTLE CAPSULE 100 10 51672-4001-2 Nortriptyline Hydrochloride 500 in 1 BOTTLE CAPSULE 500 10 51672-4001-5 Nortriptyline Hydrochloride 90 in 1 BOTTLE CAPSULE 90 10 51672-4001-6 Nortriptyline Hydrochloride 30 in 1 BOTTLE CAPSULE 30 10
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 51672-4001 NORTRIPTYLINE HYDROCHLORIDE CAPSULE [TARO PHARMACEUTICALS U.S.A., INC.] 10 Current NDC, Legacy NDC, 4 package rows 20200508_aee2c1a1-d848-4c3b-8c6d-8a4f6ce94c28.zip
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded Nortriptyline Hydrochloride ACTIVE INGREDIENT 00FN6IH15D NORTRIPTYLINE HYDROCHLORIDE CAPSULE [TARO PHARMACEUTICALS U.S.A., INC.] 8 Nortriptyline ACTIVE MOIETY BL03SY4LXB NORTRIPTYLINE HYDROCHLORIDE CAPSULE [TARO PHARMACEUTICALS U.S.A., INC.] 8 aluminum oxide INACTIVE INGREDIENT LMI26O6933 NORTRIPTYLINE HYDROCHLORIDE CAPSULE [TARO PHARMACEUTICALS U.S.A., INC.] 8 D&C Yellow NO. 10 INACTIVE INGREDIENT 35SW5USQ3G NORTRIPTYLINE HYDROCHLORIDE CAPSULE [TARO PHARMACEUTICALS U.S.A., INC.] 8 FD&C Blue NO. 1 INACTIVE INGREDIENT H3R47K3TBD NORTRIPTYLINE HYDROCHLORIDE CAPSULE [TARO PHARMACEUTICALS U.S.A., INC.] 8 FD&C Blue NO. 2 INACTIVE INGREDIENT L06K8R7DQK NORTRIPTYLINE HYDROCHLORIDE CAPSULE [TARO PHARMACEUTICALS U.S.A., INC.] 8 FD&C Green NO. 3 INACTIVE INGREDIENT 3P3ONR6O1S NORTRIPTYLINE HYDROCHLORIDE CAPSULE [TARO PHARMACEUTICALS U.S.A., INC.] 8 FD&C Red NO. 40 INACTIVE INGREDIENT WZB9127XOA NORTRIPTYLINE HYDROCHLORIDE CAPSULE [TARO PHARMACEUTICALS U.S.A., INC.] 8 ferrosoferric oxide INACTIVE INGREDIENT XM0M87F357 NORTRIPTYLINE HYDROCHLORIDE CAPSULE [TARO PHARMACEUTICALS U.S.A., INC.] 8 gelatin INACTIVE INGREDIENT 2G86QN327L NORTRIPTYLINE HYDROCHLORIDE CAPSULE [TARO PHARMACEUTICALS U.S.A., INC.] 8 magnesium stearate INACTIVE INGREDIENT 70097M6I30 NORTRIPTYLINE HYDROCHLORIDE CAPSULE [TARO PHARMACEUTICALS U.S.A., INC.] 8 shellac INACTIVE INGREDIENT 46N107B71O NORTRIPTYLINE HYDROCHLORIDE CAPSULE [TARO PHARMACEUTICALS U.S.A., INC.] 8 silicon dioxide INACTIVE INGREDIENT ETJ7Z6XBU4 NORTRIPTYLINE HYDROCHLORIDE CAPSULE [TARO PHARMACEUTICALS U.S.A., INC.] 8 sodium lauryl sulfate INACTIVE INGREDIENT 368GB5141J NORTRIPTYLINE HYDROCHLORIDE CAPSULE [TARO PHARMACEUTICALS U.S.A., INC.] 8 starch, corn INACTIVE INGREDIENT O8232NY3SJ NORTRIPTYLINE HYDROCHLORIDE CAPSULE [TARO PHARMACEUTICALS U.S.A., INC.] 8 titanium dioxide INACTIVE INGREDIENT 15FIX9V2JP NORTRIPTYLINE HYDROCHLORIDE CAPSULE [TARO PHARMACEUTICALS U.S.A., INC.] 8
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 2 of 139 · 2,761 matching rows.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.